Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Market Clinical Follow-Up Study of the Vivacit-E Vitamin E Highly Crosslinked Polyethylene HXLPE Elevated Liners in Primary THA- A Retrospective Enrollment/Prospective Follow-Up Study

NCT07150221 is registered in ClinicalTrials.gov with Zimmer Biomet as lead sponsor.

NCT NCT07150221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07150221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Market Clinical Follow-Up Study of the Vivacit-E Vitamin E Highly Crosslinked Polyethylene HXLPE Elevated Liners in Primary THA- A Retrospective Enrollment/Prospective Follow-Up Study
Lead sponsor
Zimmer Biomet
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 7, 2026
Completion date
December 31, 2027
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

avascular necrosis of bone of hip, diastrophic variant, fracture of pelvis, fused hip, osteoarthritis (oa) of the hip, protrusio acetabuli, slipped capital femoral epiphyses, traumatic arthropathy-hip